Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Plasma lysophosphatidic acid concentration and ovarian cancer.

Literature DB >> 12069669

Plasma lysophosphatidic acid concentration and ovarian cancer.

Daniel L Baker¹, Patton Morrison, Brigitte Miller, Caroline A Riely, Betsy Tolley, Anneke M Westermann, Johannes M G Bonfrer, Evert Bais, Wouter H Moolenaar, Gabor Tigyi.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12069669 DOI： 10.1001/jama.287.23.3081

Source DB: PubMed Journal: JAMA ISSN： 0098-7484 Impact factor: 56.272

Keyword Cloud
Cited

× No keyword cloud information.

53 in total

1. Lysophosphatidic acid activates lipogenic pathways and de novo lipid synthesis in ovarian cancer cells.

Authors: Abir Mukherjee; Jinhua Wu; Suzanne Barbour; Xianjun Fang
Journal: J Biol Chem Date: 2012-06-03 Impact factor: 5.157

Review 2. The human plasma lipidome.

Authors: Oswald Quehenberger; Edward A Dennis
Journal: N Engl J Med Date: 2011-11-10 Impact factor: 91.245

3. Comparison of total plasma lysophosphatidic acid and serum CA-125 as a tumor marker in the diagnosis and follow-up of patients with epithelial ovarian cancer.

Authors: Tugan Bese; Merve Barbaros; Elif Baykara; Onur Guralp; Salih Cengiz; Fuat Demirkiran; Cevdet Sanioglu; Macit Arvas
Journal: J Gynecol Oncol Date: 2010-12-31 Impact factor: 4.401

4. Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity.

Authors: Juliette Mazereeuw-Hautier; Sandra Gres; Madie Fanguin; Clotilde Cariven; Josette Fauvel; Bertrand Perret; Hugues Chap; Jean-Pierre Salles; Jean-Sébastien Saulnier-Blache
Journal: J Invest Dermatol Date: 2005-09 Impact factor: 8.551

5. Autotaxin and LPA1 and LPA5 receptors exert disparate functions in tumor cells versus the host tissue microenvironment in melanoma invasion and metastasis.

Authors: Sue-Chin Lee; Yuko Fujiwara; Jianxiong Liu; Junming Yue; Yoshibumi Shimizu; Derek D Norman; Yaohong Wang; Ryoko Tsukahara; Erzsebet Szabo; Renukadevi Patil; Souvik Banerjee; Duane D Miller; Louisa Balazs; Manik C Ghosh; Christopher M Waters; Tamas Oravecz; Gabor J Tigyi
Journal: Mol Cancer Res Date: 2014-08-26 Impact factor: 5.852

6. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.

Authors: Feng Gao; Sergio X Vasquez; Feng Su; Svetlana Roberts; Neha Shah; Victor Grijalva; Satoshi Imaizumi; Arnab Chattopadhyay; Ekambaram Ganapathy; David Meriwether; Brad Johnston; G M Anantharamaiah; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal: Integr Biol (Camb) Date: 2011-02-01 Impact factor: 2.192

7. Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer.

Authors: Feng Su; Kathy R Kozak; Satoshi Imaizumi; Feng Gao; Malaika W Amneus; Victor Grijalva; Carey Ng; Alan Wagner; Greg Hough; Gina Farias-Eisner; G M Anantharamaiah; Brian J Van Lenten; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy; Robin Farias-Eisner
Journal: Proc Natl Acad Sci U S A Date: 2010-11-01 Impact factor: 11.205